Norway
-
The Norwegian biotech company completed a fresh capital raising on Tuesday night -
The European banks have slightly boosted confidence hurt by Fortis Bank's Friday flop
-
Capped deal set to perform in secondary market, say bankers
-
The public sector’s rush to raise dollars is set to continue on Wednesday
-
Second busy day hints at strong end to September corporate issuance
-
Norwegian oil company's shares have had a wild ride since IPO
-
◆ €500m no-grow print avoids competing supply ◆ 15bp-20bp needed to seal the deal ◆ Smaller names should be prepared to pay up in August supply rush
-
◆ Second bail-in euro note to also carry a green label ◆ Trade expected on Thursday following a day of investor calls
-
A new dollar green bond in the autumn is on the cards to help the issuer meet €10bn target
-
Nordic ECM issuance has been subdued in 2023, Dealogic data shows
-
German, Norwegian and Italian deals were successfully priced on Wednesday but lacked sparkle
-
Norwegian A rated issuer does not tinker with successful formula
